Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

36.75p
   
  • Change Today:
      0.15p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 395,689
  • Market Cap: £198.60m
  • RiskGrade: 119

Company Listing Data

EPIC APH
Sector Pharma and Biotech
ISIN GB0031030819
Market Sector AIM
Market Segment AMSM
Main Indices FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
Country of register Great Britain
Currency British Pound
Market Cap £198.60m
NMS 15,000
Shares in issue 540.40m
Date Listed 23-Dec-2003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 36.75p
Change Today 0.15p
% Change 0.41 %
52 Week High 71.80
52 Week Low 34.50
Volume 395,689
Shares Issued 540.40m
Market Cap £198.60m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.68% above the market average82.68% above the market average82.68% above the market average82.68% above the market average82.68% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
66.65% below the market average66.65% below the market average66.65% below the market average66.65% below the market average66.65% below the market average
12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average
Income
4.89% above the market average4.89% above the market average4.89% above the market average4.89% above the market average4.89% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 18-Apr-2024

Time Volume / Share Price
16:35 22,340 @ 36.75p
16:35 195 @ 36.75p
16:35 114 @ 36.75p
16:35 114 @ 36.75p
16:35 114 @ 36.75p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page